Found: 29
Select item for more details and to access through your institution.
Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05861-9
- By:
- Publication type:
- Article
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00859-5
- By:
- Publication type:
- Article
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 408, doi. 10.1002/ajh.26800
- By:
- Publication type:
- Article
NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134568
- By:
- Publication type:
- Article
A Case of Unicentric Castleman Disease and Langerhans Cell Histiocytosis: Two Entities in One Lymph Node.
- Published in:
- Clinical Laboratory, 2018, v. 64, n. 11/12, p. 1943, doi. 10.7754/Clin.Lab.2018.180547
- By:
- Publication type:
- Article
Diffuse Large B Cell Lymphoma Coexistent with Follicular Cell Lymphoma.
- Published in:
- Clinical Laboratory, 2018, v. 64, n. 7/8, p. 1311, doi. 10.7754/Clin.Lab.2018.180320
- By:
- Publication type:
- Article
Extramedullary Blast Crisis in a Patient with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.
- Published in:
- Clinical Laboratory, 2018, v. 64, p. 193, doi. 10.7754/Clin.Lab.2017.170807
- By:
- Publication type:
- Article
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3369, doi. 10.1007/s00277-023-05452-7
- By:
- Publication type:
- Article
Assessment of High-Resolution Surface Soil Moisture Products over the Qinghai–Tibet Plateau for 2009–2017.
- Published in:
- Atmosphere, 2023, v. 14, n. 2, p. 302, doi. 10.3390/atmos14020302
- By:
- Publication type:
- Article
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax‐based therapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 2, p. 1, doi. 10.1002/cam4.6885
- By:
- Publication type:
- Article
Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.725336
- By:
- Publication type:
- Article
Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia.
- Published in:
- Frontiers in Oncology, 2021, p. N.PAG, doi. 10.3389/fonc.2021.554503
- By:
- Publication type:
- Article
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720965411
- By:
- Publication type:
- Article
Apoptosis inducing effect of ponicidin in leukemia K562 cells and its mechanisms of action.
- Published in:
- China Journal of Chinese Materia Medica, 2010, v. 35, n. 16, p. 2161, doi. 10.4268/cjcmm20101628
- By:
- Publication type:
- Article
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study.
- Published in:
- Journal of Internal Medicine, 2024, v. 295, n. 2, p. 216, doi. 10.1111/joim.13738
- By:
- Publication type:
- Article
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 3, p. 329, doi. 10.1111/joim.13581
- By:
- Publication type:
- Article
Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle.
- Published in:
- Experimental & Therapeutic Medicine, 2023, v. 26, n. 6, p. N.PAG, doi. 10.3892/etm.2023.12274
- By:
- Publication type:
- Article
Influence of autologous blood transfusion in liver transplantation in patients with hepatitis B on the function and hemorheology of red blood cells.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 2, p. 1205, doi. 10.3892/etm.2017.4587
- By:
- Publication type:
- Article
Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 400, doi. 10.1007/s00280-005-1029-9
- By:
- Publication type:
- Article
Whole Exome Sequencing Identified a Novel Heterozygous Mutation in HMBS Gene in a Chinese Patient With Acute Intermittent Porphyria With Rare Type of Mild Anemia.
- Published in:
- Frontiers in Genetics, 2018, p. 1, doi. 10.3389/fgene.2018.00129
- By:
- Publication type:
- Article
Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 5, p. N.PAG, doi. 10.1038/s41419-019-1569-2
- By:
- Publication type:
- Article
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01437-1
- By:
- Publication type:
- Article
Oridonin-induced apoptosis of Jurkat cells and its mechanism.
- Published in:
- Comparative Clinical Pathology, 2004, v. 13, n. 2, p. 65, doi. 10.1007/s00580-004-0521-7
- By:
- Publication type:
- Article
Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells.
- Published in:
- Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12567
- By:
- Publication type:
- Article
Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1018154
- By:
- Publication type:
- Article
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
- By:
- Publication type:
- Article
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
- By:
- Publication type:
- Article
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01199-8
- By:
- Publication type:
- Article
Recent applications and strategies in nanotechnology for lung diseases.
- Published in:
- Nano Research, 2021, v. 14, n. 7, p. 2067, doi. 10.1007/s12274-020-3180-3
- By:
- Publication type:
- Article